Information and resources on coronavirus (COVID-19)
Join us to learn about emerging applications in tissue regeneration, oral infections, SARS-CoV-2, and clinical translation. The program will feature the latest research by CiPD faculty, trainees, and fellows. We welcome you to engage with our panel of experts on the challenges and opportunities for innovation in oral health care.
The CiPD is bridging Penn Dental Medicine and Penn’s School of Engineering and Applied Sciences with cutting-edge research and training to accelerate the development of new solutions and devices to address unmet needs in oral health, while also recruiting the next generation of leaders in these fields.
The CiPD bridges basic/translational researchers and clinicians with engineers and data scientists working in diverse fields. Their work ranges from robotics, AI and nanotechnology to diagnose and control oral diseases to developing a plant-based platform for affordable therapeutics. While biofilm microbiomes and regeneration of craniofacial tissues are being assessed using 3D bioprinting and organ-on-a-chip platforms.
The CiPD provides funding opportunities to study disease mechanisms and to accelerate innovative diagnostic and therapeutic solutions. Current programs include Pilot Fund and Fellowship Awards with topics ranging from COVID-19 and Artificial Intelligence in Dentistry to Oral Health Care Devices.
By leveraging the expertise in dental medicine and engineering sciences, the CiPD will train the next generation dentists, engineers and scientists with interdisciplinary skills. The training program focuses on mechanistic understanding of oral diseases/craniofacial disorders, precision diagnostics and affordable therapies targeted to susceptible populations.
A gift to the Center for Innovation & Precision Dentistry accelerates research into new tools to diagnose, treat and prevent diseases and otherwise address unmet oral health needs. There are various ways to make a contribution, including online.
With one of its key missions to develop a new generation of scientists at the interface of dental medicine and engineering, the CiPD has selected its inaugural class of fellows for its new postdoctoral training program.
Dr. Michel Koo, co-director of CiPD, will be the featured speaker in this virtual lecture April 5, 2022, noon - 1 pm. Learn more and register.
Behind Biotech Podcast talks with Dr. Michel Koo on innovation in oral health.
Chewing gum could be a new tool to block the spread of COVID-19. Dr. Henry Daniell from Penn Dental Medicine tells HealthCall's Lee Kelso how his lab has infused chewing gum with a plant-based enzyme that acts like flypaper to trap the virus, plus block the receptor so it can't enter your body.
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus.